Lapatinib-induced inhibition of ovarian function is counteracted by the STAT3 pathway both in vivo and in vitro

Mostrar otras versiones (1)

The present study was designed to ascertain whether lapatinib, a tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR), affects ovarian reserve and fertility potential in a mouse model. Female C57BL/6 mice were treated with either vehicle or lapatinib (100 or 200 mg/kg/day orally) for...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Qiuyue, Feng, Xue, Li, Xi, Chen, Ge, Chen, Jing, Yang, Bin, Li, Kezhen, Ai, Jihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388577/
https://www.ncbi.nlm.nih.gov/pubmed/32582968
http://dx.doi.org/10.3892/or.2020.7660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388577/
https://www.ncbi.nlm.nih.gov/pubmed/32582968
http://dx.doi.org/10.3892/or.2020.7660

Ejemplares similares